Ongoing selection for a uniquely human null allele of SIGLEC12 in world‐wide populations may protect against the risk of advanced carcinomas
Shoib S. Siddiqui,
Michael Vaill,
Ajit Varki
Affiliations
Shoib S. Siddiqui
Departments of Medicine and Cellular and Molecular Medicine Glycobiology Research and Training Center, and Center for Academic Research and Training in Anthropogeny University of California San Diego CA USA
Michael Vaill
Departments of Medicine and Cellular and Molecular Medicine Glycobiology Research and Training Center, and Center for Academic Research and Training in Anthropogeny University of California San Diego CA USA
Ajit Varki
Departments of Medicine and Cellular and Molecular Medicine Glycobiology Research and Training Center, and Center for Academic Research and Training in Anthropogeny University of California San Diego CA USA